Insulin Inhibits Pertussis Toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a Novel Interaction Between Insulin Receptors and G-proteins
Overview
Authors
Affiliations
Insulin modifies cellular responsiveness to some hormones which operate via guanine nucleotide binding proteins (G-proteins); also, G-proteins have been implicated in some actions of insulin. Using pertussis toxin-catalyzed [32P]ADP-ribosylation of Gi as an index of G-protein conformation, we evaluated interaction of insulin receptors with G-proteins. In isolated rat liver plasma membranes, insulin treatment for 10 min inhibited [32P]ADP-ribosylation of Gi by 50%. This effect was half-maximal at 2 x 10(-8) M. A similar effect was observed with rat adipocyte plasma membranes with half-maximal effect at 1 x 10(-8) M. Pertussis toxin activity itself was uninfluenced by insulin, as ribosylation of tubulin or heat-treated bovine serum albumin was unaltered. Elevated Mg2+ diminished basal ADP-ribosylation, but insulin inhibition occurred at all Mg2+ levels between 0 and 1 mM. Insulin inhibition was independent of ATP (20 microM to 10 mM), and GTP (0-100 microM) concentrations. Because both protein kinase C and purified insulin receptor phosphorylate purified Gi in vitro, we examined Gi as a substrate for the insulin receptor tyrosine kinase in vivo. Triton-extracts of isolated rat hepatocytes which had been 32Pi labeled and treated with insulin were immunoprecipitated with a polyclonal anti-Gi antiserum. The dominant labeled phosphoprotein had a molecular weight of 42 kDa, consistent with the alpha-subunit of Gi, contained only phosphoserine, and was unaffected in its phosphorylation by insulin. These results indicate the existence of a novel pathway for physiological "cross-talk" between insulin and other hormones and further suggests that the insulin receptor may interact with regulatory G-proteins via biochemical mechanisms not directly involving the tyrosine kinase activity of the insulin receptor.
Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity.
Ma G, Lopez-Sanchez I, Aznar N, Kalogriopoulos N, Pedram S, Midde K Mol Biol Cell. 2015; 26(23):4209-23.
PMID: 26378251 PMC: 4642855. DOI: 10.1091/mbc.E15-08-0553.
Girnita L, Worrall C, Takahashi S, Seregard S, Girnita A Cell Mol Life Sci. 2013; 71(13):2403-27.
PMID: 24276851 PMC: 4055838. DOI: 10.1007/s00018-013-1514-y.
Hawkes C, Amritraj A, MacDonald R, Jhamandas J, Kar S Mol Neurobiol. 2007; 35(3):329-45.
PMID: 17917122 DOI: 10.1007/s12035-007-0021-2.
Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins.
Kreuzer J, Nurnberg B, Krieger-Brauer H Biochem J. 2004; 380(Pt 3):831-6.
PMID: 15025562 PMC: 1224225. DOI: 10.1042/BJ20031659.
Unbalanced expression of the different subunits of elongation factor 1 in diabetic skeletal muscle.
Reynet C, Kahn C Proc Natl Acad Sci U S A. 2001; 98(6):3422-7.
PMID: 11248094 PMC: 30669. DOI: 10.1073/pnas.051630398.